Higher infection risk in MS and other brain diseases

Credibility

Interest

Key Takeaway

People with MS had a higher chance of getting infections both before and after diagnosis, but infections explained only part of the higher risk of dying.

What They Found

Researchers looked at large groups of people with MS, Alzheimer’s and Parkinson’s and compared them to similar people without these diseases. They found people with MS had about twice the risk of infections compared with similar people without MS. The study saw similar increased infection risks for Alzheimer’s and Parkinson’s patients, and the higher risk was present even in the years before the diseases were officially diagnosed. Getting an infection after being diagnosed did add some risk of dying, but it did not explain most of the increased death risk. The results suggest the brain diseases themselves—or early changes before diagnosis—may affect the body’s ability to fight infections.

Who Should Care and Why

People with MS and their caregivers should care because infections are more common and can cause extra problems like more fatigue or time in hospital. Think of the immune system like a security team: the study suggests this team may be weaker or disrupted in people with MS, so infections can get in more easily. Doctors and nurses should be aware of this so they can watch for infections, give vaccines when appropriate, and treat infections quickly. Caregivers can help by spotting early signs (fever, cough, bladder changes) and helping with hygiene and doctor visits. This may affect daily routines, like being more careful about hand washing, staying up-to-date on vaccines, and checking in with health providers quickly when someone seems unwell.

Important Considerations

The study shows a link but cannot prove exactly why infections are more common—other factors might play a role. The size of the increased risk varied between the two groups they studied, so results might differ by country or population. Because infections explained only part of the higher death risk, other disease-related factors still matter for long-term health.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Living with MS MS Progression MS Diagnostics

Article Topics:

Alzheimer’s diseaseParkinson’s diseaseinfectionsmultiple sclerosis

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain communications often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News